ALX Oncology Holdings Inc. (ALXO) Misses Q4 EPS by 7c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.42), $0.07 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Home Depot beats estimates, reaffirms fiscal 2026 guidance
• Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
• Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)